Shirakawa Tadayoshi, Takahashi Yasuhiro, Wada Kei, Hirota Junko, Takao Toshifumi, Ohmori Daijiro, Fukuyama Keiichi
Department of Biology, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan.
Biochemistry. 2005 Sep 20;44(37):12402-10. doi: 10.1021/bi0508441.
During the purification of recombinant Bacillus thermoproteolyticus ferredoxin (BtFd) from Escherichia coli, we have noted that some Fe-S proteins were produced in relatively small amounts compared to the originally identified BtFd carrying a [4Fe-4S] cluster. These variants could be purified into three Fe-S protein components (designated as V-I, V-II, and V-III) by standard chromatography procedures. UV-vis and EPR spectroscopic analyses indicated that each of these variants accommodates a [3Fe-4S] cluster. From mass spectrometric and protein sequence analyses together with native and SDS gel electrophoresis, we established that V-I and V-II contain the polypeptide of BtFd associated with acyl carrier protein (ACP) and with coenzyme A (CoA), respectively, and that V-III is a BtFd dimer linked by a disulfide bond. The crystal structure of the BtFd-CoA complex (V-II) determined at 1.6 A resolution revealed that each of the four complexes in the crystallographic asymmetric unit possesses a [3Fe-4S] cluster that is coordinated by Cys(11), Cys(17), and Cys(61). The polypeptide chain of each complex is superimposable onto that of the original [4Fe-4S] BtFd except for the segment containing Cys(14), the fourth ligand to the [4Fe-4S] cluster of BtFd. In the variant molecules, the side chain of Cys(14) is rotated away to the molecular surface, forming a disulfide bond with the terminal sulfhydryl group of CoA. This covalent modification may have occurred in vivo, thereby preventing the assembly of the [4Fe-4S] cluster as observed previously for Desulfovibrio gigas ferredoxin. Possibilities concerning how the variant molecules are formed in the cell are discussed.
在从大肠杆菌中纯化重组嗜热解蛋白酶芽孢杆菌铁氧化还原蛋白(BtFd)的过程中,我们注意到,与最初鉴定的携带[4Fe-4S]簇的BtFd相比,一些铁硫蛋白的产量相对较少。通过标准色谱程序,这些变体可以被纯化到三种铁硫蛋白组分中(分别命名为V-I、V-II和V-III)。紫外可见光谱和电子顺磁共振光谱分析表明,这些变体中的每一个都容纳一个[3Fe-4S]簇。通过质谱分析、蛋白质序列分析以及天然和十二烷基硫酸钠凝胶电泳,我们确定V-I和V-II分别包含与酰基载体蛋白(ACP)和辅酶A(CoA)相关的BtFd多肽,并且V-III是通过二硫键连接的BtFd二聚体。以1.6埃分辨率测定的BtFd-CoA复合物(V-II)的晶体结构表明,晶体学不对称单元中的四个复合物中的每一个都拥有一个由半胱氨酸(11)、半胱氨酸(17)和半胱氨酸(61)配位的[3Fe-4S]簇。除了包含半胱氨酸(14)的片段外,每个复合物的多肽链都可以叠加到原始[4Fe-4S] BtFd的多肽链上,半胱氨酸(14)是BtFd的[4Fe-4S]簇的第四个配体。在变体分子中,半胱氨酸(14)的侧链旋转到分子表面,与CoA的末端巯基形成二硫键。这种共价修饰可能在体内发生,从而阻止了[4Fe-4S]簇的组装,正如之前在巨大脱硫弧菌铁氧化还原蛋白中观察到的那样。文中讨论了关于变体分子如何在细胞中形成的可能性。